Cargando…
Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier on behalf of the American Academy of Dermatology, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901237/ https://www.ncbi.nlm.nih.gov/pubmed/35271937 http://dx.doi.org/10.1016/j.jaad.2022.03.004 |
_version_ | 1784664317954621440 |
---|---|
author | Moreno-Ramírez, David Duarte-Ferreras, Miguel A. Ojeda-Vila, Teresa García-Morales, Irene Conejo-Mir, Maria D. Fernández-Orland, Almudena Sánchez-del-Campo, Ana I. Eiris, Noemí Carrizosa, Ana M. Ruiz-de-Casas, Andrés de-la-Torre, Jose M. Herrerías-Esteban, Juan M. Ferrándiz, Lara |
author_facet | Moreno-Ramírez, David Duarte-Ferreras, Miguel A. Ojeda-Vila, Teresa García-Morales, Irene Conejo-Mir, Maria D. Fernández-Orland, Almudena Sánchez-del-Campo, Ana I. Eiris, Noemí Carrizosa, Ana M. Ruiz-de-Casas, Andrés de-la-Torre, Jose M. Herrerías-Esteban, Juan M. Ferrándiz, Lara |
author_sort | Moreno-Ramírez, David |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8901237 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Published by Elsevier on behalf of the American Academy of Dermatology, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89012372022-03-08 Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study Moreno-Ramírez, David Duarte-Ferreras, Miguel A. Ojeda-Vila, Teresa García-Morales, Irene Conejo-Mir, Maria D. Fernández-Orland, Almudena Sánchez-del-Campo, Ana I. Eiris, Noemí Carrizosa, Ana M. Ruiz-de-Casas, Andrés de-la-Torre, Jose M. Herrerías-Esteban, Juan M. Ferrándiz, Lara J Am Acad Dermatol Research Letter Published by Elsevier on behalf of the American Academy of Dermatology, Inc. 2022-11 2022-03-07 /pmc/articles/PMC8901237/ /pubmed/35271937 http://dx.doi.org/10.1016/j.jaad.2022.03.004 Text en © 2022 Published by Elsevier on behalf of the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Research Letter Moreno-Ramírez, David Duarte-Ferreras, Miguel A. Ojeda-Vila, Teresa García-Morales, Irene Conejo-Mir, Maria D. Fernández-Orland, Almudena Sánchez-del-Campo, Ana I. Eiris, Noemí Carrizosa, Ana M. Ruiz-de-Casas, Andrés de-la-Torre, Jose M. Herrerías-Esteban, Juan M. Ferrándiz, Lara Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study |
title | Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study |
title_full | Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study |
title_fullStr | Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study |
title_full_unstemmed | Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study |
title_short | Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study |
title_sort | telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the covid-19 pandemic: a longitudinal prospective feasibility study |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901237/ https://www.ncbi.nlm.nih.gov/pubmed/35271937 http://dx.doi.org/10.1016/j.jaad.2022.03.004 |
work_keys_str_mv | AT morenoramirezdavid telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy AT duarteferrerasmiguela telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy AT ojedavilateresa telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy AT garciamoralesirene telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy AT conejomirmariad telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy AT fernandezorlandalmudena telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy AT sanchezdelcampoanai telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy AT eirisnoemi telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy AT carrizosaanam telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy AT ruizdecasasandres telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy AT delatorrejosem telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy AT herreriasestebanjuanm telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy AT ferrandizlara telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy |